Pharmacy Podcast Network

How can we prevent our older adults with prediabetes from developing diabetes?  Susan is a board certified health and wellness coach.  She is a certified with the CDC diabetes prevention program and owner of Weighting4You.  She will walk us through the use of continuous glucose monitors (CGMs) to assist with lowering HgbA1c, counseling tips for patients on GLP-1 RAs, and more.  I hope you enjoy our conversation.   The Geriatric Pharmacy Focus podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user’s own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. Connect with Tamara here:  www.linkedin.com/in/tamara-ruggles-491882251 www.thedeprescribingclinic.com Connect with Susan here:linkedin.com/in/susanward https://weighting4you.com/

🎙️ Podcast Show Notes — McKesson ideaShare 2025 | Part One: Frontline Voices of Pharmacy Innovation Presented by the Pharmacy Podcast Network | On-site Press Coverage In Part One of our exclusive press coverage from McKesson ideaShare 2025 in Nashville, we spotlight some of the most influential voices shaping the future of independent pharmacy. This episode features five compelling interviews that explore digital health, public policy, clinical innovation, and pharmacy entrepreneurship. 💡 Featured Guests: Ashton Maaraba, President of IPC Digital Health, shares how Independent Pharmacy Cooperative is leading the charge in technology-driven patient care and empowering pharmacies with scalable digital tools. U.S. Representative Buddy Carter, a pharmacist and legislator from Georgia, offers a boots-on-the-ground policy perspective on PBM reform, scope expansion, and fighting for the future of community pharmacy. Greg Reybold, VP of Healthcare Policy at APCI, delivers key insights on how independent pharmacy advocacy is gaining momentum on Capitol Hill. Dr. Beshoy Gerges, CEO of St. Mary Pharmacy, discusses the intersection of clinical excellence and business strategy in high-performing community pharmacies. Christopher Darling, Pharmacy Owner Darling Apothecary Chuck Schneider from Lifecykel talks about functional wellness, medicinal mushrooms, and expanding pharmacy's role in holistic health. 🎧 Available now on all major podcast platforms. 🔗 https://mckessonideashare.com/  Sponsored by Independent Pharmacy Cooperative (IPC) https://www.ipcrx.com/   Stay tuned for Part Two — featuring more interviews with pharmacy leaders shaping the industry’s next chapter.

In this engaging discussion, John Nosta, an AI and technology theorist and founder of NostaLab, joins Stephen Beckman, CEO of YARAL Pharma. They explore how AI and Large Language Models are revolutionizing pharmaceutical manufacturing and healthcare. Topics include the balance between innovation and ethics, the philosophical implications of AI on human creativity, and the evolving roles of healthcare professionals. They emphasize the necessity of human-AI collaboration and a patient-centered approach in shaping the future of medicine.

In this episode, YARAL Pharma CEO, Stephen Beckman joins clinical sports pharmacist Jessica Beal, PharmD. to discuss an important topic for athletes and active individuals – the role topical NSAID patches can play in acute pain management. Listeners can visit www.YARALPharma.com to learn more about the company and its products or connect on LinkedIn.    Diclofenac Epolamine Topical System 1.3%    Diclofenac Epolamine Topical System 1.3% is a nonsteroidal anti-inflammatory drug (NSAID) used for treating acute pain from minor strains, sprains, and bruises in adults and children aged 6 and older.     Serious side effects may include increased risk of cardiovascular and gastrointestinal (GI) events. NSAIDs can raise the risk of heart attack, stroke, gastrointestinal bleeding, ulceration, and perforation of the stomach and intestines, which can be fatal. The risk for serious cardiovascular events may occur early in treatment and may increase with duration of use. Elderly patients and those with a history of peptic ulcer disease or GI bleeding are at higher risk for serious GI events.    Do not use in patients who are allergic to diclofenac or any of its ingredients, or have a history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Do not use in the setting of coronary artery bypass graft surgery. Avoid use on broken skin. Discontinue immediately if signs of hypersensitivity occur.      Patients should be informed about the warning signs and symptoms of liver problems. Discontinue use if abnormal liver tests persist or worsen or if signs of liver disease develop. Avoid using Diclofenac Epolamine Topical System 1.3% in patients with severe heart failure unless the benefits are expected to outweigh the risks.    The most common side effects include itching, nausea, and headache. Patients should stop use and consult their doctor at the first sign of skin rash or other signs of sensitivity.    Patients should ask their doctor if Diclofenac Epolamine Topical System 1.3% is right for them. For more information and Full Prescribing Information including Boxed Warning and Important Safety Information, visit www.yaralpharma.com   Dr. Beal is not affiliated with YARAL Pharma. All views and opinions regarding pain management are solely her own and are not attributable to YARAL or the Pharmacy Podcast Network. 

Tune in to a multi-episode recap of the Retail Business Conference with returning special guest host Adam Robinson, Owner of Save-Rite Drugs in Lexington, Kentucky. Receive the highlights from Cardinal Health customers, employees, services and more at RBC 2025. This episode's topic is navigating Part B Biling for CGM Devices. This discussion will dive into the nuances that make Medicare billing a challenge for pharmacies and ways Cardinal may be able to help.

Welcome to the first episode of Supply, Trust, and the Business of Pharmacy hosted by Andrew Crawford.

This Week in Pharmacy – July 25, 2025 Episode Summary: This week, we spotlight a growing but often overlooked threat to patient safety and healthcare integrity: the diversion of non-controlled substances. While most discussions around drug diversion focus on controlled substances, a troubling pattern has emerged involving medications not classified as controlled—yet still susceptible to misuse, theft, and exploitation. Our guest is Alan McGill, a Senior Supervisory Special Agent with over 30 years of investigative experience, including 23 years in law enforcement. Agent McGill is a nationally recognized expert on drug diversion, having trained thousands across healthcare and law enforcement. In this episode, he sheds light on how non-controlled substances are being diverted within healthcare settings, why it’s happening more frequently, and what pharmacies and healthcare systems must do to detect and prevent it. We explore: Common myths about non-controlled medications and diversion risk Real-world cases and investigative red flags Compliance blind spots in retail and institutional pharmacy settings Actionable recommendations for pharmacists, techs, and healthcare leadership The role of education, oversight, and reporting in stopping this silent epidemic Plus, Agent McGill discusses his work with NASCSA and offers insight into how national policy and local practices can align to protect both patients and professionals. Don’t miss this essential conversation for pharmacy leaders, compliance officers, and healthcare professionals committed to medication safety. 🎧 Listen now and stay informed.  📢 Brought to you by IPC and iCare+, supporting pharmacy excellence and compliance integrity. The Silent Threat: Diversion of Non-Controlled Substances in Healthcare | TWIRx

Building Your LTC Pharmacy at Home Business (Part 2)  🎙️ Presented by the Pharmacy Podcast Network | Sponsored by RxSafe Eyecon In Part 2 of our special three-part series “Building Your LTC Pharmacy at Home Business,” we go beyond the vision and focus on the systems that make long-term care at home work — financially, operationally, and clinically. This episode features insights from top leaders in pharmacy program development and technology: Jennifer Whalen, MBA – Medsense, guiding us through payer alignment, compliance, and program structure. Susan Rhoads & Cole Page – GeriMed, on how they’ve helped hundreds of community pharmacies shift into reimbursable LTC care models. Brian Glaves – RxSafe Eyecon, breaking down how automation and verification tools drive accurate dispensing, documentation, and revenue capture. Key Topics: Billing & Reimbursement: Learn how to transition from traditional retail models to get paid for LTC-at-home services. Technology Integration: Eyecon, RxSafe, and software platforms help streamline packaging, compliance, and inventory tracking. Home-Based Patient Care: Pharmacists are becoming central to aging-in-place strategies—this is how to build trust and care continuity. Implementation Strategy: Practical guidance on referral networks, payer contracting, and working with care teams. 📲 Listen now to learn how to operationalize your LTC-at-home pharmacy and turn it into a sustainable, profitable service model. 🔗 Learn more at RxSafe.com 🎧 Available wherever you get your podcasts – Pharmacy Podcast Network 💡 Brought to you by RxSafe and Eyecon – Smart tech for serious care delivery.

The show discussions are Modern Medical Mafia and Patient Protector - two projects to help expose PBMs. We discussed ways independent pharmacy owners can get involved in local legislation and patient education about PBMs and how they impact pharmacies. 

Building Your LTC Pharmacy at Home Business (Part 3) In Part 3 of our Eyecon by RxSafe-sponsored series, we dive deep into how independently owned pharmacies can scale their business and impact patient lives by expanding into Long-Term Care at Home (LTC-at-Home). Joined by industry leaders Joe Moose of Moose Pharmacy and Joe Williams of APEX Pharmacy Consulting, we break down the Top 5 ways community pharmacies can lead the LTC-at-Home movement — offering actionable strategies to support medically complex patients, differentiate services, and integrate more deeply into the care team. This episode delivers a blueprint for pharmacies ready to go beyond traditional retail and build recurring revenue with purpose-driven patient care. 🔑 Key Topics Covered: Targeting Medically Complex Patients with Medication Management Collaborative care models with prescribers and specialists In-home and telehealth MTM opportunities Specialized Packaging & Home Delivery for Adherence Leveraging multi-dose packs and sync programs Branding delivery as a “concierge medication service” 24/7 Clinical Support for At-Home Patients Establishing on-call pharmacist access Building trust through urgent delivery capabilities Referral Networks with Care Providers Engaging discharge planners, case managers, and home health agencies Marketing LTC-at-home services B2B Proving Preventive Value to Payers & Families Reducing hospitalizations and adverse events Exploring partnerships with Medicare Advantage and ACOs 🎧 Listen now and learn how LTC-at-Home is becoming a game-changer for independent pharmacies aiming to diversify revenue, deepen patient relationships, and become indispensable to care teams in 2025 and beyond. 🔗 Subscribe, share, and stay tuned for Part 3!  📍 Brought to you by Eyecon by RxSafe — the automation partner empowering pharmacies to do more with less.